Hairy cell leukemia classification: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 19: Line 19:
* '''The male to female ratio is approximately<br> 4 to 1'''<br>
* '''The male to female ratio is approximately<br> 4 to 1'''<br>
* '''The median age at diagnosis is 55 years'''<br>
* '''The median age at diagnosis is 55 years'''<br>
* '''Less than 10% lymphocytosis on peripheral blood smear'''<br>
* '''Less than 10% lymphocytosis is observed'''<br>
* '''Decreased level of monocyte on peripheral blood smear'''<br>
* '''Decreased level of monocyte on peripheral blood smear'''<br>
* '''Decreased hemoglobin level in approximately 85% of the patients'''<br>
* '''Decreased hemoglobin level in approximately 85% of the patients'''<br>
Line 30: Line 30:
* '''The male to female ratio is approximately<br> 2 to 1'''<br>
* '''The male to female ratio is approximately<br> 2 to 1'''<br>
* '''The median age at diagnosis is greater than 70 years'''<br>
* '''The median age at diagnosis is greater than 70 years'''<br>
* '''greater than 90% lymphocytosis on peripheral blood smear'''<br>
* '''greater than 90% lymphocytosis is observed'''<br>
* '''Normal level of monocyte on peripheral blood smear'''<br>
* '''Normal level of monocyte on peripheral blood smear'''<br>
* '''Normal hemoglobin level in most of the patients'''<br>
* '''Normal hemoglobin level in most of the patients'''<br>

Revision as of 20:24, 19 October 2015

Hairy cell leukemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hairy cell leukemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hairy cell leukemia classification On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hairy cell leukemia classification

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hairy cell leukemia classification

CDC on Hairy cell leukemia classification

Hairy cell leukemia classification in the news

Blogs on Hairy cell leukemia classification

Directions to Hospitals Treating Hairy cell leukemia

Risk calculators and risk factors for Hairy cell leukemia classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Haytham Allaham, M.D. [2]

Overview

  • Hairy cell leukemia may be classified into two subtypes: Hairy cell leukemia (classic) and hairy cell leukemia variant.[1]

Classification

  • Hairy cell leukemia may be classified into two subtypes: Hairy cell leukemia (classic) and hairy cell leukemia variant.[1]
  • Hairy cell leukemia variant is still considered a provisional entity at this time, as the WHO is unable to recognize it as distinct diseases due to insufficient evidence.[2]
  • The algorithm below illustrates characteristic findings associated with each subtypes:[3]


 
 
 
 
 
 
 
Hairy cell leukemia classification
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Hairy cell leukemia
 
 
 
 
 
Hairy cell leukemia variant
 
 
 
 
 
 
 
 
 
  • Occurs in approximately 95% of the cases
  • The male to female ratio is approximately
    4 to 1

  • The median age at diagnosis is 55 years
  • Less than 10% lymphocytosis is observed
  • Decreased level of monocyte on peripheral blood smear
  • Decreased hemoglobin level in approximately 85% of the patients
  • Thrombocytopenia is present in approximately 80% of the patients
  • CD103+, CD11c+, and CD25+ on immunophenotype
  • DBA.44+, Cyclin D1+, and Annexin A1+ on immunohistochemistry
  • Presence of BRAF V600E mutation on cytogenetic tests
 
 
 
 
 
  • Occurs in approximately 5% of the cases
  • The male to female ratio is approximately
    2 to 1

  • The median age at diagnosis is greater than 70 years
  • greater than 90% lymphocytosis is observed
  • Normal level of monocyte on peripheral blood smear
  • Normal hemoglobin level in most of the patients
  • Normal platelets count in most of the patients
  • CD103+, CD11c+, and CD25- on immunophenotype
  • DBA.44+, Cyclin D1+, and Annexin A1- on immunohistochemistry
  • Presence of BRAF wild type mutation on cytogenetic tests
 
 
 
 
 
 
 
 



References

  1. 1.0 1.1 Hairy cell leukemia. Wikipedia (2015) https://en.wikipedia.org/wiki/Hairy_cell_leukemia#Classification Accessed on October, 17 2015
  2. Campo E, Swerdlow SH, Harris NL, Pileri S, Stein H, Jaffe ES (2011). "The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications". Blood. 117 (19): 5019–32. doi:10.1182/blood-2011-01-293050. PMC 3109529. PMID 21300984.
  3. Matutes E (2006). "Immunophenotyping and differential diagnosis of hairy cell leukemia". Hematol Oncol Clin North Am. 20 (5): 1051–63. doi:10.1016/j.hoc.2006.06.012. PMID 16990106.


Template:WikiDoc Sources